Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valeria Cardinali

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Annals of Hematology|July 8, 2025
Venetoclax plus azacitidine as genetic-driven bridge-to-transplant therapy for IDH2-mutated acute myeloid leukaemia (AML) refractory to intensive chemotherapy: proof-of-concept case reportsGaetano Cimino, Matteo Caridi, Valeria Cardinali, et al.
American Journal of Hematology|August 19, 2024
Starry sky pattern predicts RAS pathway activation in NPM1-mutated acute myeloid leukemiaAlessandra Venanzi, Valeria Cardinali, Vincenzo Perriello, et al.
Cancers|August 10, 2024
The Leukemic <i>Isocitrate Dehydrogenase (IDH) 1/2</i> Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs)Sara Pierangeli, Serena Donnini, Valerio Ciaurro, et al.
International Journal of Molecular Sciences|November 25, 2023
Blinatumomab Redirects Donor Lymphocytes against CD19<sup>+</sup> Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell TransplantationAntonella Mancusi, Francesco Zorutti, Loredana Ruggeri, et al.
Annals of Hematology|May 22, 2026
Durable remission despite transplantation with active disease in therapy-related NUP98::TOP1-rearranged acute myeloid leukemiaGaetano Cimino, Rebecca Sembenico, Francesco Zorutti, et al.
Leukemia|January 22, 2026
Immunomodulatory effect of dasatinib plus blinatumomab versus ponatinib plus blinatumomab in newly diagnosed Ph+ acute lymphoblastic leukemiaMichela Ansuinelli, Nadia Peragine, Maria Stefania De Propris, et al.
Haematologica|August 1, 2024
Ponatinib alone or with chemo-immunotherapy in heavily pre treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life studyFrancesca Kaiser, Monia Lunghi, Deborah Cardinali, et al.
British Journal of Haematology|December 9, 2022
Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemiaDaniele Sorcini, Filomena De Falco, Marco Gargaro, et al.
Leukemia|March 3, 2021
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AMLIlaria Gionfriddo, Lorenzo Brunetti, Federica Mezzasoma, et al.
Leukemia & Lymphoma|July 15, 2023
Digital droplet PCR for T315I BCR::ABL1 KD mutation assessment in adult Ph-positive acute lymphoblastic leukemia with a minimal residual disease increaseDeborah Cardinali, Marco Beldinanzi, Michela Ansuinelli, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Annals of Hematology|July 8, 2025
Venetoclax plus azacitidine as genetic-driven bridge-to-transplant therapy for IDH2-mutated acute myeloid leukaemia (AML) refractory to intensive chemotherapy: proof-of-concept case reportsGaetano Cimino, Matteo Caridi, Valeria Cardinali, et al.
American Journal of Hematology|August 19, 2024
Starry sky pattern predicts RAS pathway activation in NPM1-mutated acute myeloid leukemiaAlessandra Venanzi, Valeria Cardinali, Vincenzo Perriello, et al.
Cancers|August 10, 2024
The Leukemic <i>Isocitrate Dehydrogenase (IDH) 1/2</i> Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs)Sara Pierangeli, Serena Donnini, Valerio Ciaurro, et al.
International Journal of Molecular Sciences|November 25, 2023
Blinatumomab Redirects Donor Lymphocytes against CD19<sup>+</sup> Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell TransplantationAntonella Mancusi, Francesco Zorutti, Loredana Ruggeri, et al.
Annals of Hematology|May 22, 2026
Durable remission despite transplantation with active disease in therapy-related NUP98::TOP1-rearranged acute myeloid leukemiaGaetano Cimino, Rebecca Sembenico, Francesco Zorutti, et al.
Leukemia|January 22, 2026
Immunomodulatory effect of dasatinib plus blinatumomab versus ponatinib plus blinatumomab in newly diagnosed Ph+ acute lymphoblastic leukemiaMichela Ansuinelli, Nadia Peragine, Maria Stefania De Propris, et al.
Haematologica|August 1, 2024
Ponatinib alone or with chemo-immunotherapy in heavily pre treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life studyFrancesca Kaiser, Monia Lunghi, Deborah Cardinali, et al.
British Journal of Haematology|December 9, 2022
Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemiaDaniele Sorcini, Filomena De Falco, Marco Gargaro, et al.
Leukemia|March 3, 2021
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AMLIlaria Gionfriddo, Lorenzo Brunetti, Federica Mezzasoma, et al.
Leukemia & Lymphoma|July 15, 2023
Digital droplet PCR for T315I BCR::ABL1 KD mutation assessment in adult Ph-positive acute lymphoblastic leukemia with a minimal residual disease increaseDeborah Cardinali, Marco Beldinanzi, Michela Ansuinelli, et al.
Pageof 3